Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effects of treatment outside of clinical trials. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillmeyer, Kari R., Miller, Donald R., Glickman, Mark E., Qian, Shirley X., Klings, Elizabeth S., Maron, Bradley A., Hanlon, Joseph T., Rinne, Seppo T., Wiener, Renda S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020250/
https://www.ncbi.nlm.nih.gov/pubmed/33868640
http://dx.doi.org/10.1177/20458940211001714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020250/
https://www.ncbi.nlm.nih.gov/pubmed/33868640
http://dx.doi.org/10.1177/20458940211001714

Ejemplares similares